- ... similar between patients with GCB and non-GCB/ABC DLBCL while low to moderate quality evidence from 3 ... free survival in patients with the non-GCB/ABC DLBCL subtype (HRs ranged from 2-2.27). 2. ...
- ... impact of Germinal Center (GC)/ Activated B-Cell (ABC) classification analysed by immunochemistry, FISH analysis and GEP, in relapsed/refractory diffuse large B-Cell lymphoma (DLBCL): The Bio-CORAL study; Blood; Conference: 52nd Annual ...
- ... ORCHARRD trial (Ofatumumab rituximab chemoimmunotherapy ASCT relapsed refractory DLBCL). Funded by GlaxoSmithKline. Non-personal financial Non-specific ...
6 results